Identification of a novel potent CDK inhibitor degrading cyclinK with a superb activity to reverse trastuzumab-resistance in HER2-positive breast cancer in vivo
2023 · European Journal of Medicinal Chemistry · 7 citations
https://doi.org/10.1016/j.ejmech.2023.116014